High Yielding, Multigram-Scale Synthesis of TBAJ-876 Fragment, 876A-B
Preprint
- 24 April 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
TBAJ-876 is an anti-tuberculosis drug shown to have high activity against multi-drug resistant tuberculosis (TB). We report a very efficient synthesis of the TBAJ-876 fragment 876A-B using an aldol condensation strategy starting from 6-bromo-3,4-dihydroquinolin-2(H)-one. The synthesis has been accomplished at multigram scale without the need of chromatography purification steps.Keywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation
This publication has 2 references indexed in Scilit:
- Phase 2 trial of a novel tuberculosis drug launchedThe Lancet Microbe, 2024
- 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channelBioorganic & Medicinal Chemistry, 2019